InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by GREATHOUSE KENNETH, Executive. Insider active across 1 company, notably Zosano Pharma Corp. In total, 6 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €11k. History available since 17 May 2021. The latest transaction was disclosed on 23 November 2021 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
10,000 shares@ US$0.601814.9% of flowCommon StockSEC:0001567619-21-021177:0
10,000 shares@ US$0.601814.9% of flowCommon StockSEC:0001567619-21-021177
15,000 shares0Common StockSEC:0001567619-21-012085
15,000 shares0Common StockSEC:0001567619-21-012085:0
21,000 shares@ US$0.729135.1% of flowCommon StockSEC:0001567619-21-010664
21,000 shares@ US$0.729135.1% of flowCommon StockSEC:0001567619-21-010664:0
6 of 6 declarations
About GREATHOUSE KENNETH
Kenneth Greathouse is a Director at Zosano Pharma Corp, a biopharmaceutical company. In this role, he contributes to the governance and strategy of the company, which focuses on developing innovative treatments. Greathouse plays a key role in Zosano's strategic direction.
